677 материалов по теме, собраны автоматически из проверенных источников
Demographics, Tumor Biology and Treatment Outcomes of Male Breast Cancer Patients From a Tertiary Cancer Center in North India: A Real-World Study Cureus
Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer Business Wire
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance The American Journal of Managed Care
ASPEN-09-03 Trial Aims to Build the Case for Evorpacept in Post–T-DXd HER2+ Breast Cancer OncLive
Treatment Options When Metastatic Triple-Negative Breast Cancer Becomes Unresponsive to Chemotherapy Everyday Health
Peter MacCallum Cancer Centre Highlights AI Advances in Breast Cancer Oncodaily
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.
Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer. Chemotherapy before or after surgery remains the standard treatment regimen for stage I–III TNBC. Only a small portion of patients can benefit from targeted therapy with PARP inhibitors because of BRCA mutations. However, resistance to…
Could Letrozole, a Breast Cancer Drug, Help Treat Uterine Fibroids? Black Doctor
Olubukola Ayodele: Global Oncology Lessons From Breast Cancer Care in China Oncodaily
An RNA-based treatment showed a survival benefit in mice with breast cancer spread to bone Stock Titan
BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer Bioengineer.org
2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances Bioengineer.org
2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances Bioengineer.org
Breast cancer survivors face fertility challenges, review finds Bioengineer.org